Patanjali's new products: Diapers, sanitary napkins planned next year
What's the story
Patanjali is expanding its range of products even further. According to spokesperson SK Gupta Tijarawala, the FMCG brand is looking to launch diapers and sanitary napkins next year. The new offerings will hit the Rs. 16,000cr market in the first quarter of the next financial year. In the last fiscal year, Patanjali registered a turnover of Rs. 10,500cr.
History
Patanjali's drastic growth in the last two years
Patanjali was founded by Ramdev and Acharya Balkrishna in 2006; it aimed to use ayurveda to create swadeshi health products. Its growth in the last two years has been unprecedented: since 2016, it has jumped 26 places to 19th on Forbes Annual India Rich List 2017. Days ago, it was deemed India's most trusted FMCG brand in the Brand Trust Report India Study 2017.
Data
Patanjali aiming Rs. 1L crore turnover in five years
Ad guru Gullu Sen estimates India's ayurvedic-and-yoga-market at $490bn, and Ramdev is ruling it. Brokerage firm IIFL Associates predicts Patanjali's revenue would touch $3bn by 2020. Patanjali has itself said it is aiming a turnover of Rs. 1L crore in the next five years.
Growth
What's next for the multi-crore business?
Though it started with healthcare products, Patanjali has now diversified into other sectors including education, food and energy (it was working on generating electricity using bulls). Apart from that, it's planning to launch a 'swadeshi' line of clothes next year. In private security, it has launched Parakrami Suraksha Private Ltd with the help of retired army and BSF officers.
Quality
However, Patanjali products have failed quality assessment tests
It is noteworthy that Patanjali products have failed several quality assessment tests conducted by Haridwar's Ayurveda and Unani Office. In May'17, an RTI query revealed that 32 out of 82 Ayurvedic products that were tested didn't meet recommended quality standards. 18 samples of Ayurveda drugs were also found to be sub-standard. In fact, over 40% of Ayurvedic products tested were sub-standard.